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Background: Obstructive sleep apnea (OSA) is a chronic and progressive disease. OSA is 
associated with increased cardiovascular morbidity and mortality, the risk being more frequently 
encountered with severe degrees of OSA. Increased sympathetic activation and impaired cardiac 
autonomic control as reflected by depressed baroreceptor reflex sensitivity (BRS) are possible 
mechanisms involved in the cardiovascular complications of OSA. However, it is not known 
at what stage of OSA that changes in BRS appear. The aim of this study was to evaluate BRS 
in patients with mild OSA.
Methods: The study population consisted of 81 overweight patients with mild OSA and 46 
body weight-matched non-OSA subjects. BRS, apnea-hypopnea index, body mass index, and 
metabolic parameters were assessed. The phenylephrine test was used to measure BRS.
Results: Patients in the OSA group were slightly but significantly older than the non-OSA 
population (50.3±9.3 years vs 45.7±11.1 years, P=0.02). Body mass index, percentage body 
fat, blood pressure, fasting glucose, insulin, and lipid levels did not differ between the OSA 
patients and non-OSA subjects. Absolute BRS values in patients with mild OSA and non-OSA 
subjects (9.97±6.70 ms/mmHg vs 10.51±7.16 ms/mmHg, P=0.67) and BRS values proportional 
to age-related and sex-related reference values (91.4%±22.7% vs 92.2%±21.8%, P=0.84) did 
not differ from each other. BRS ,50% of the sex-specific reference value was found in 6% of 
patients with mild OSA and in 2% of non-OSA subjects (P=0.29).
Conclusion: Patients with mild OSA did not show evidence of disturbed BRS in comparison 
with weight-matched non-OSA controls.
Keywords: obstructive sleep apnea, baroreceptor reflex sensitivity
Introduction
Obstructive sleep apnea (OSA) is a common sleep disturbance affecting approximately 
15%–25% of the population in the working-aged group, and has been found to be an 
independent risk factor for increased morbidity and mortality.1,2 Epidemiological stud-
ies have demonstrated a strong link between OSA and cardiovascular diseases such 
as hypertension, coronary artery disease, atrial fibrillation, stroke, and heart failure.3–5 
Sympathetic activation has been proposed to be an important factor in the development 
of these diseases in patients with OSA.6–8 It has been postulated that the sympathetic 
nervous system is activated in response to stimulation of chemoreceptors induced 
by intermittent asphyxia and hypoxemia as well as the repeated arousals associated 
with OSA.9–11 There are several reports of sympathetic activation in severe OSA, as 
evidenced by depressed baroreceptor reflex sensitivity (BRS).9,11–20 Impaired BRS has 
been used as a marker of cardiac autonomic dysfunction in many serious diseases, 
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including diabetes, chronic heart failure, and coronary artery 
disease.21–23 Depressed BRS has been found to be a significant 
predictor of arrhythmic death in patients recovering from 
acute myocardial infarction.22,24–26
OSA is a chronic, insidious disease that can progress 
independently of other risk factors, including weight gain,1,27,28 
and in particular, the more severe stages of OSA have been 
linked to an increased risk of cardiovascular morbidity and 
mortality. However, little is known about the stage of OSA at 
which the cardiovascular changes appear. It is known that BRS 
is impaired in the severe stages of OSA, a phenomenon that is 
independent of obesity. Surprisingly, there have been very few 
studies examining this issue, and these have been inconclusive, 
perhaps due to the small sample sizes. Thus, there is no firm 
evidence, whether BRS may be disturbed already in the early 
stages of the disease, ie, in mild OSA12 or even in snoring 
patients without OSA.29–31 To address this issue, we conducted 
the largest study to date determining BRS in patients with mild 
OSA and body weight-matched non-OSA controls.
Materials and methods
Design overview
The objective of the study was to compare BRS in patients 
with mild OSA (apnea-hypopnea index [AHI] 5–15/hour) and 
non-OSA subjects (AHI ,5/hour). Our working hypothesis 
was that BRS would be impaired already in snorers with 
mild OSA. The patients were given oral and written informa-
tion about the trial protocol and they provided their written 
consent. The study protocol was approved by the research 
ethics committee of the Northern Savo Hospital District 
and is registered at ClinicalTrials.gov with the identifier 
NCT00486746.
Patients
The study was conducted in a single center, ie, Kuopio 
University Hospital, Finland. All the study subjects were 
consecutively recruited from the patients referred from 
the primary health care centers to the outpatient clinics 
of otorhinolaryngology and respiratory medicine of the 
Kuopio University Hospital due to a clinical suspicion 
of sleep-disordered breathing. The recruitment started in 
October 2004 and ended in December 2006. Patients were 
assigned to undergo nocturnal cardiorespiratory monitoring. 
The weight and height were recorded, and the upper airway 
structure of each patient was reviewed. The inclusion criteria 
in the OSA group were: working age (18–65 years); body 
mass index 28–40 kg/m2; and AHI 5–15 events/hour. We 
excluded patients on any active treatment for OSA, as well 
as pregnant women and those with chronic kidney, thyroid, 
or liver disease. The control group consisted of subjects who 
fulfilled the first two inclusion criteria but did not exhibit any 
signs of OSA (AHI ,5 events/hour, Figure 1).
Procedures and measurements
Nocturnal six-channel ambulatory cardiorespiratory monitor-
ing (Embla, Broomfield, CO, USA) at home was conducted 
in accordance with accepted guidelines for diagnosing 
OSA.32 Nasal flow was assessed by a nasal flow detector, 
thoracic and abdominal movements were estimated by two 
piezoelectric belts, oxygen saturation and heart rate were 
determined by finger pulse oximetry, and body position 
was monitored. Apnea was defined as a cessation ($90%) 
of airflow for $10 seconds. Hypopnea was defined as a 
reduction ($30%) of airflow for $10 seconds with oxygen 
desaturation $4%. The AHI was defined as the number of 
apneas and hypopneas per hour, and mild OSA was defined as 
AHI 5–15 events/hour.33,34 Other parameters such as arterial 
oxygen saturation, time and percentage with arterial oxygen 
saturation below 90%, and heart rate were assessed. Many 
routine biochemical parameters were also measured.
Assessment of BRS
BRS was always evaluated between 10 am and 2 pm using 
a modification of the method originally described by Smyth 
et al.48 In brief, a bolus injection of phenylephrine 150 µg 
was administered into the antecubital vein to produce a rapid 
increase in blood pressure and a concomitant reduction in 
heart rate (increase in R-R interval [RRI]). Beat-to-beat 
RRIs values were plotted against systolic arterial pressure 
(SAP) values from the preceding cardiac cycle [ie, RRI(i) 
vs SAP(i – 1)] during the period in which blood pressure 
increased after injection of phenylephrine. A linear regression 
analysis between RRI(i) and SAP(i – 1) was performed and 
can be expressed as follows: RRI(i) (ms/mmHg), where i is 
one individual cardiac cycle and i – 1 is the cardiac beat pre-
ceding the i beat. The slope of the regression line (b) represents 
BRS, a is a constant, and b represents the coefficient derived 
from the linear regression (first-order equation, Figure 2). 
Only tests with correlation coefficients of r.0.80 or that 
were statistically significant (P,0.05) were accepted. The 
phenylephrine test was repeated at 10-minute intervals up to 
five times in order to obtain three acceptable  measurements. 
The average of the three measurements was used for assess-
ment of BRS. In two cases, we were not able to obtain any 
acceptable BRS values because of technical problems or 
ectopic beats. Further, BRS was assessed in proportion to 
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age-related and sex-related reference values, with these being 
calculated as percentages.36 The coefficient of variation and 
correlation coefficient of two measurements performed at 
3-month intervals were 7.4% and 0.903, respectively.37
Blood pressure and anthropometric 
measurements
Blood pressure was measured from the right arm in the sitting 
position, and recorded three times, after 10 minutes of rest, 
using a standard sphygmomanometer. The mean value of 
the measurements was used for analyses. At the study site, a 
trained nurse measured height, weight, waist circumference, 
and blood pressure.
Statistical analysis
Mean values and standard deviations were calculated to 
describe the characteristics of the two study groups. The 
Student’s t-test and Fisher’s Exact test were used to assess 
equality between the groups. The normality of the variables 
was determined using the Kolmogorov-Smirnov test. For 
variables with a right skewed distribution, a logarithmic 
transformation was applied before further analysis. We 
Arrival of patient referrals
(n=627)
Department of otolaryngology
or respiratory medicine,
Kuopio University Hospital     
Sleep recordings 
Inclusion, n=83
Age range 18–65 years
BMI  28–40 kg/m2  
OSA group (n=81) 
Visit to ENT specialist
otolaryngological examination
oral and written consent   
Non-OSA group (n=48) 
AHI <5 
Physiological measurements
(BRS)  
Physiological measurements
(BRS)  
AHI 5–15 
Visit to study nurse
anthropometric data
blood samples and pressure   
Visit to ENT specialist
otolaryngological examination
oral and written consent   
Visit to study nurse
anthropometric data
blood samples and pressure   
Patients not
fulfilling inclusion
criteria (n=544)   
Participants not
willing to
participate
(n=2)    
Figure 1 Study flowchart. 
Abbreviations: AHI, apnea-hypopnea index; BMI, body mass index; BRS, baroreceptor reflex sensitivity; ENT, ear, nose, and throat; OSA, obstructive sleep apnea.
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Figure 2 The baroreceptor reflex sensitivity slope method describes the relationship between the change in R-R interval in response to the change of systolic blood pressure 
of the preceding cardiac cycle. The slope of the regression line corresponds to an arterial baroreflex sensitivity of 8.67 ms/mmHg with an acceptable correlation coefficient 
of 0.95. 
Abbreviations: RRI, R-R interval; SAP, systolic arterial pressure.
report medians and ranges for nonparametric variables 
in Tables 1 and 2. The differences in risk are reported as 
odds ratios with 95% confidence intervals. In the second-
ary analysis of continuous variables between the OSA and 
non-OSA groups, the unequal sample size had a power of 
80% to detect a statistical significance of 0.05 (effect size 
0.51) for a difference between the groups. All characteristics 
and variables were analyzed with Statistical Package for 
Social Sciences version 19 software (SPSS Inc., Chicago, 
IL, USA).
Results
The body mass index, percentage body fat, blood pressure, 
fasting glucose, insulin, and lipid levels did not differ between 
the OSA patients and non-OSA subjects (Table 1). Patients 
in the OSA group were slightly but significantly older than 
the non-OSA population (50.3±9.3 years vs 45.7±11.1 years, 
P=0.02).
The absolute BRS values (9.97±6.70 ms/mmHg vs 
10.51±7.16 ms/mmHg, P=0.67) as well as BRS values 
proportional to age-related and sex-related reference 
values (91.4%±22.7% vs 92.2%±21.8%, P=0.84) did not 
differ between the patients with mild OSA and the non-
OSA subjects (Table 2). Furthermore, 6.2% of participants 
in the OSA group and 2.1% in the non-OSA group had 
BRS ,50% of the sex-specific reference value (P=0.29). 
In both groups, men had higher BRS values than women 
(11.0±7.0 ms/mmHg vs 7.2±5.0 ms/mmHg, P=0.02 
and 12.8±7.8 ms/mmHg vs 7.6±5.3 ms/mmHg, P=0.01, 
respectively). Non-OSA subjects had higher fasting serum 
high-density lipoprotein cholesterol levels (P,0.05), 
higher average oxygen saturation levels (P,0.05), and a 
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Table 1 Clinical characteristics in mild OSa and non-OSa 
groups
Mild OSA 
n=81 
(SD)
Non-OSA 
n=48 
(SD)
Significance 
P-value
Age (years) 50 (9) 46 (11) 0.02
Sex (male/female) 60/21 27/21 0.03
Time between  
sleep and BRS  
measurements (days)
72 (93) 96 (96) 0.17
Body mass index (kg/m2) 32.5 (3.0) 31.7 (3.7) 0.17
Systolic blood  
pressure (mmHg)
130 (11) 132 (12) 0.40
Diastolic blood  
pressure (mmHg)
81 (8) 83 (10) 0.72
Fasting plasma  
glucose (mmol/L)
6.16 (1.9) 5.89 (1.1) 0.37
Fasting serum  
insulin (mU/L)
12.06 (5.99) 11.58 (5.67) 0.68
Fasting serum  
cholesterol (mmol/L)
4.70 (0.82) 5.00 (0.89) 0.06
Fasting serum HDL  
cholesterol (mmol/L)
1.06 (0.29) 1.19 (0.39) 0.02
Fasting serum  
triglycerides (mmol/L)
1.73 (1.11) 1.54 (0.89) 0.32
Hypertension (n) 34 13 0.07
Antihypertensive  
medication (n)
38 17 0.14
Hypercholesterolemia (n) 26 5 0.001
Hypercholesterolemia  
medication (n)
26 5 0.001
Coronary artery disease (n) 3 0 0.24
Diabetes (n) 7 2 0.28
Diabetes medication (n) 7 1 0.13
Current smoker (n) 21 11 0.44
Apnea-hypopnea index 9.3 (3.3) 1.9 (1.4) ,0.01
Mean oxygen saturation (%) 94.0 (1.4) 94.8 (1.7) 0.02
Time with oxygen  
saturation ,90% (minutes)
4.6 (0.4,  
304.0)
1.8 (0.1, 
337.0)
0.01
Percent time with  
oxygen saturation ,90%
1.0 (0.1,  
46.06)
0.4 (0.1,  
63.4)
0.04
Note: The data are shown as the mean ± standard deviation, frequency, or median 
with range. 
Abbreviations: BRS, baroreceptor reflex sensitivity; OSA, obstructive sleep apnea; 
SD, standard deviation; HDL, high-density lipoprotein.
Table 2 Baroreflex sensitivity in mild OSA and non-OSA 
groups
Mild OSA 
n=81 
(SD)
Non-OSA 
n=48 
(SD)
Significance 
P-value
Baroreflex sensitivity  
in phenylephrine test  
(ms/mmHg)
9.97 (6.70) 10.51 (7.16) 0.67
Percentage of reference  
value matched for age  
and sex
91.4 (22.7) 92.2 (21.8) 0.84
Notes: The data are shown as the mean ± standard deviation; the Student’s t-test 
for means. 
Abbreviations: OSA, obstructive sleep apnea; SD, standard deviation.
Table 3 Univariate correlates of BRS values in mild OSA and 
non-OSA groups
BRS%
Mild OSA Non-OSA
Age -0.664* -0.500*
Body mass index -0.122 -0.027
Percentage body fat -0.301* - 0.413*
Systolic blood pressure -0.248* -0.420*
Diastolic blood pressure 0.205 -0.157
Fasting plasma glucose -0.261 -0.206
Fasting serum insulin -0.118 -0.138
Fasting serum cholesterol 0.161 0.034
Fasting serum HDL cholesterol 0.134 -0.189
Fasting serum triglycerides -0.136 -0.189
aHi 0.146 0.120
Mean oxygen saturation 0.297 -0.215
Time with oxygen saturation ,90% -0.394 0.279
Notes: Values are shown as Pearson’s correlation coefficient and Spearman’s 
coefficient for variables that were not normally distributed; *statistically significant 
at P,0.05. 
Abbreviations: AHI, apnea-hypopnea index; BRS, baroreceptor reflex sensitivity; 
OSA, obstructive sleep apnea; HDL, high-density lipoprotein.
lower AHI (P,0.001) when compared with OSA patients 
(Table 1). In both groups, BRS was inversely correlated 
with age, systolic blood pressure, and percentage body 
fat (Table 3).
Discussion
The main finding of this study was that BRS as measured by 
the intravenous phenylephrine test during wakefulness was 
not impaired in patients with mild OSA when compared with 
non-OSA subjects. Only 6% of patients with mild OSA and 
2% of non-OSA subjects displayed signs of impaired BRS.
There are several studies that have assessed BRS in 
patients with OSA. Regardless of the techniques used for 
measurement of BRS, most have demonstrated that severe 
OSA is associated with a reduction in BRS. Ward et al 
found that BRS was impaired during wakefulness in sub-
jects with severe OSA which they assessed in three ways, 
ie, the sequence technique, the spectral transfer function 
technique, and the alpha index technique.15 Similarly, 
reductions in BRS were detected in patients with moderate-
to-severe OSA using either the Valsalva technique16 or 
the nitroprusside test.9 In addition, there are studies using 
the sequence method reporting decreased nocturnal BRS 
in severe OSA.12,13,17 Further, it is known that treatment 
with continuous positive airway pressure improves BRS 
in OSA patients, suggesting that the impairment of BRS 
is reversible.17,19
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The effect of mild-to-moderate OSA on BRS is less clear. 
In our study, assessment of BRS did not reveal any differ-
ences between patients with mild OSA and their non-OSA 
controls. This is in agreement with Ryan et al.12 In their study, 
BRS was lower in patients with severe OSA when compared 
with patients having mild-to-moderate OSA or non-OSA 
 subjects. However, there was no difference in BRS between 
the patients with mild-to-moderate OSA and non-OSA 
 subjects. In contrast, our findings and those of Ryan et al,12 
Noda et al,16 and Ward et al15 reported reduced values of BRS 
in patients with mild-to-moderate OSA than those detected 
in healthy controls. Our study and that reported by Ryan et al 
used non-OSA snorers as the reference group, whereas the 
reference groups in the studies by Noda et al and Ward et al 
consisted of healthy controls, but this is unlikely to account 
for the differences in the results. There is a report that BRS 
does not differ in non-OSA snorers and healthy controls dur-
ing wakefulness.29 Interestingly, in the study by Schöbel et al, 
BRS during the daytime was lower in patients with nocturnal 
snoring than in healthy non-snorers.31 However, BRS was not 
assessed with the phenylephrine technique, but calculated 
from spontaneous fluctuations of heart rate and blood pres-
sure using the squared root of the ratio of heart rate variability 
and systolic blood pressure variability. BRS assessed with 
the phenylephrine method measures the heart rate response 
to an increase in blood pressure (vagal activation), whereas 
BRS assessed from spontaneous blood pressure fluctuations 
includes heart rate responses to both increased (vagal activa-
tion), as well as decreased (vagal withdrawal) blood pressure. 
Thus, although the phenylephrine method and BRS are based 
on spontaneous blood pressure oscillations and both assess 
autonomic reflexes induced by blood pressure change, they 
cannot be compared with each other.
The underlying mechanism responsible for the reduced 
BRS is believed to be sympathetic activation caused by noc-
turnal upper airway collapses, repetitive asphyxia resulting 
in hypoxia and arousals.38,39 In addition, hypoxia over time 
leading to enhanced chemoreceptor activity may also play a 
role in the chronic sympathetic activation.40,41 Severe OSA 
is associated with significant cardiovascular morbidity and 
mortality.2,42 Sympathetic activation is considered to be one of 
the key mechanisms linking OSA to cardiovascular morbidity 
and mortality.38,41,43 However, it is not clear at what stage of 
OSA the harmful changes in vascular function appear. We 
have demonstrated that endothelial function is well preserved 
in patients with mild OSA.44 On the other hand, mild OSA 
is associated with increased activation of the inflammatory 
system, a symptom that could be normalized by weight loss 
after successful lifestyle intervention.45,46 These findings 
indicate that the inflammatory system is more susceptible 
to OSA than cardiovascular regulation.
Decreased BRS is considered to be one of the early 
markers of autonomic dysfunction in many diseases, includ-
ing hypertension,22 diabetes,21 chronic heart failure,23 and 
coronary artery disease.24,47 Recent studies have shown that 
BRS is decreased even in the early asymptomatic stages 
of coronary artery atherosclerosis,48 and impaired BRS 
predicted cardiovascular death in middle-aged subjects 
without cardiovascular disease.49 BRS measured by the phe-
nylephrine method has been shown to have strong prognostic 
value in predicting mortality in patients with cardiovascular 
disease.22,26,50 Therefore, this method was applied in our 
study to assess BRS. While this method has advantages for 
cardiovascular risk stratification,51,52 it has the drawback that, 
due to the intravenous administration of phenylephrine, it 
cannot be undertaken when the patient is asleep.
Our results indicate that BRS measured by the phenyleph-
rine test may not be decreased in patients with mild OSA 
when compared with non-OSA controls. Since OSA has a 
natural tendency to worsen over time27,53 and severe OSA 
is known to be associated with increased cardiovascular 
mortality, intervention in the early stages of the disease is 
essential in order to prevent progression of the disease and 
development of serious comorbidities.
There are some limitations to this study. The control group 
consisted of patients referred to hospital due to suspicion of 
sleep-disordered breathing, ie, snoring. After careful testing, 
these patients did not show any signs of OSA. In addition, as 
mentioned earlier, there is a controversy as to whether BRS is 
sustained in non-OSA snorers,29–31 so it is unlikely that using 
non-OSA snorers would introduce any bias in the interpreta-
tion of our results. In addition, the use of weight-matched 
groups meant that we had metabolic-matched groups, which 
is of crucial importance when assessing vascular function. 
The diagnosis of OSA was based on cardiorespiratory 
recordings from a single night. On the other hand, in routine 
practice, repeated recordings are extremely demanding, and 
the findings of single-night recordings have been found to 
be reliable in most patients.54 The patients in the OSA group 
were slightly older than in the non-OSA group and there were 
also more males in the OSA group. Since age and sex are 
important contributors to BRS, in addition to absolute BRS 
values, we used age-adjusted and sex-adjusted BRS values 
in these analyses.
In conclusion, BRS was found to be well preserved in 
patients with mild OSA. This suggests that cardiac autonomic 
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dysfunction appears later along the progression to more 
severe stages of OSA.
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